Friday, March 13, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

in News
CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims
Share on LinkedinShare on WhatsApp

CVS Health, Walgreens Boots Alliance and Walmart have agreed to pay about $13.8 billion to resolve thousands of lawsuits accusing the pharmacy chains of mishandling opioid painkillers.

In a filing with the Securities and Exchange Commission Walgreens disclosed that it had agreed to pay about $5.7 billion over 15 years. CVS said Wednesday it had agreed to pay about $5 billion over 10 year and Walmart has agreed to pay $3.1 billion, according to two people familiar with the matter.

Neither company admitted wrongdoing.

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” CVS’s general counsel, Thomas Moriarty, said in a statement. The company did not admit wrongdoing.

Walgreens said in its SEC filing that it “continues to believe it has strong legal defenses” and will defend itself against any future lawsuits not covered by the settlement.

In more than 3,300 lawsuits, beginning in 2017, state and local governments accused drugmakers of downplaying the risks of their opioid pain medicines. Pharmacies were accused of ignoring red flags that prescriptions were being diverted into illegal trafficking.

Overdoses involving opioids, including prescription pills and heroin, surged further during the Covid pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021, according to the Centers for Disease Control and Prevention.

Tags: CVS HealthopioidsWalgreensWalmart

Related Posts

Dallas Fed Allays Energy Price Driven Inflation Concerns
News

US Treasury allows temporary Russian oil purchases to slow price increases

US rejects latest World Trade Organization reform proposal
News

US rejects latest World Trade Organization reform proposal

Adobe to acquire Semrush in $1.9 Billion deal
News

Adobe CEO Shantanu Narayen steps down

International Energy Agency says Iran war has caused historic oil market disruption
News

International Energy Agency says Iran war has caused historic oil market disruption

Bumble welcomes Founder Whitney Wolfe Herd into CEO role
News

Bumble shares surge 20% following return to ‘women-first foundation’

Costco CFO reports e-commerce gains of 20.5%
News

Costco shoppers file lawsuit seeking tariff refunds

Oil rises as UK reports cargo ship attack in the Strait of Hormuz
News

Oil rises as UK reports cargo ship attack in the Strait of Hormuz

Oracle shares decline as AI investment skyrockets
News

Oracle stock jumps 10% following ‘exceptional quarter’

Nebius secures $3 billion deal with Meta
News

NVIDIA to invest $2 billion in Nebius

Cop President Daily Media Statement And Latest Announcements
News

Bill Ackman files IPO for Pershing Square on the NYSE

No Result
View All Result

Recent Posts

  • What is creatine, what does it do and should you be taking it?
  • Art and classic car auctions top $600 million despite Iran war
  • Should I book travel now? What the Iran war means for your plans
  • US Treasury allows temporary Russian oil purchases to slow price increases
  • US rejects latest World Trade Organization reform proposal

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.